- Conditions
- Cutaneous Melanoma by AJCC V7 Stage
- Interventions
- Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin
- Procedure
- Lead sponsor
- Melanoma and Skin Cancer Trials Limited
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Hodgkin's Lymphoma, Mature T-cell Lymphoma, Multiple Myeloma
- Interventions
- lenalidomide (Revlimid) and romidepsin (Istodax)
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Cancer of the Uterine Cervix
- Interventions
- Not listed
- Lead sponsor
- Trans Tasman Radiation Oncology Group
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2014
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Breast Cancer, Breast Cancer Recurrent
- Interventions
- rPBI
- Radiation
- Lead sponsor
- University Health Network, Toronto
- Other
- Eligibility
- 18 Years to 99 Years · Female only
- Enrollment
- 171 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 3
- States / cities
- New York, New York • Richmond, Virginia
- Conditions
- Fungal Infection, Haematological Malignancy, Blood Cancer, Infectious Disease
- Interventions
- genotype-directed dosing with dosing software based on therapeutic drug monitoring
- Other
- Lead sponsor
- The University of Queensland
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 104 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Advanced Cancer
- Interventions
- questionnaires
- Behavioral
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 288 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Colonic Cancer, Rectal Cancer, Non Small Cell Lung Cancer
- Interventions
- Sevoflurane, Propofol, Lidocaine IV
- Drug
- Lead sponsor
- Peter MacCallum Cancer Centre, Australia
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 254 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 3
- States / cities
- Cleveland, Ohio • Pittsburgh, Pennsylvania • Houston, Texas